Global Non-alcoholic Steatohepatitis Market Research Report 2024(Status and Outlook)

Global Non-alcoholic Steatohepatitis Market Research Report 2024(Status and Outlook)



Report Overview:

Non-alcoholic steatohepatitis(NASH) is an advanced form ofnon-alcoholic fatty liver disease(NAFLD). NAFLD is caused by buildup of fat in the liver. When this buildup causes inflammation and damage, it is known as NASH, which can lead to scarring of the liver.

The Global Non-alcoholic Steatohepatitis Market Size was estimated at USD 3094.41 million in 2023 and is projected to reach USD 9520.55 million by 2029, exhibiting a CAGR of 20.60% during the forecast period.

This report provides a deep insight into the global Non-alcoholic Steatohepatitis market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Non-alcoholic Steatohepatitis Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Non-alcoholic Steatohepatitis market in any manner.

Global Non-alcoholic Steatohepatitis Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

AstraZeneca

Pfizer

GSK

Novo Nordisk

Roche

AbbVie

Galectin Therapeutics

Galmed Pharmaceuticals

Gilead

Intercept pharma

Non-alcoholic Steatohepatitis

Takeda

Market Segmentation (by Type)

Solid

Liquid

Market Segmentation (by Application)

Oral

Parenteral

Geographic Segmentation
  • North America (USA, Canada, Mexico)
  • Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
  • South America (Brazil, Argentina, Columbia, Rest of South America)
  • The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
  • Industry drivers, restraints, and opportunities covered in the study
  • Neutral perspective on the market performance
  • Recent industry trends and developments
  • Competitive landscape & strategies of key players
  • Potential & niche segments and regions exhibiting promising growth covered
  • Historical, current, and projected market size, in terms of value
  • In-depth analysis of the Non-alcoholic Steatohepatitis Market
  • Overview of the regional outlook of the Non-alcoholic Steatohepatitis Market:
Key Reasons to Buy this Report:
  • Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
  • This enables you to anticipate market changes to remain ahead of your competitors
  • You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
  • The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
  • Provision of market value (USD Billion) data for each segment and sub-segment
  • Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
  • Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
  • Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
  • Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
  • The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
  • Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
  • Provides insight into the market through Value Chain
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • 6-month post-sales analyst support
Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Note: this report may need to undergo a final check or review and this could take about 48 hours.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Non-alcoholic Steatohepatitis Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Non-alcoholic Steatohepatitis
1.2 Key Market Segments
1.2.1 Non-alcoholic Steatohepatitis Segment by Type
1.2.2 Non-alcoholic Steatohepatitis Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Non-alcoholic Steatohepatitis Market Overview
2.1 Global Market Overview
2.1.1 Global Non-alcoholic Steatohepatitis Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Non-alcoholic Steatohepatitis Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Non-alcoholic Steatohepatitis Market Competitive Landscape
3.1 Global Non-alcoholic Steatohepatitis Sales by Manufacturers (2019-2024)
3.2 Global Non-alcoholic Steatohepatitis Revenue Market Share by Manufacturers (2019-2024)
3.3 Non-alcoholic Steatohepatitis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Non-alcoholic Steatohepatitis Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Non-alcoholic Steatohepatitis Sales Sites, Area Served, Product Type
3.6 Non-alcoholic Steatohepatitis Market Competitive Situation and Trends
3.6.1 Non-alcoholic Steatohepatitis Market Concentration Rate
3.6.2 Global 5 and 10 Largest Non-alcoholic Steatohepatitis Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Non-alcoholic Steatohepatitis Industry Chain Analysis
4.1 Non-alcoholic Steatohepatitis Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Non-alcoholic Steatohepatitis Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Non-alcoholic Steatohepatitis Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Non-alcoholic Steatohepatitis Sales Market Share by Type (2019-2024)
6.3 Global Non-alcoholic Steatohepatitis Market Size Market Share by Type (2019-2024)
6.4 Global Non-alcoholic Steatohepatitis Price by Type (2019-2024)
7 Non-alcoholic Steatohepatitis Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Non-alcoholic Steatohepatitis Market Sales by Application (2019-2024)
7.3 Global Non-alcoholic Steatohepatitis Market Size (M USD) by Application (2019-2024)
7.4 Global Non-alcoholic Steatohepatitis Sales Growth Rate by Application (2019-2024)
8 Non-alcoholic Steatohepatitis Market Segmentation by Region
8.1 Global Non-alcoholic Steatohepatitis Sales by Region
8.1.1 Global Non-alcoholic Steatohepatitis Sales by Region
8.1.2 Global Non-alcoholic Steatohepatitis Sales Market Share by Region
8.2 North America
8.2.1 North America Non-alcoholic Steatohepatitis Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Non-alcoholic Steatohepatitis Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Non-alcoholic Steatohepatitis Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Non-alcoholic Steatohepatitis Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Non-alcoholic Steatohepatitis Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 AstraZeneca
9.1.1 AstraZeneca Non-alcoholic Steatohepatitis Basic Information
9.1.2 AstraZeneca Non-alcoholic Steatohepatitis Product Overview
9.1.3 AstraZeneca Non-alcoholic Steatohepatitis Product Market Performance
9.1.4 AstraZeneca Business Overview
9.1.5 AstraZeneca Non-alcoholic Steatohepatitis SWOT Analysis
9.1.6 AstraZeneca Recent Developments
9.2 Pfizer
9.2.1 Pfizer Non-alcoholic Steatohepatitis Basic Information
9.2.2 Pfizer Non-alcoholic Steatohepatitis Product Overview
9.2.3 Pfizer Non-alcoholic Steatohepatitis Product Market Performance
9.2.4 Pfizer Business Overview
9.2.5 Pfizer Non-alcoholic Steatohepatitis SWOT Analysis
9.2.6 Pfizer Recent Developments
9.3 GSK
9.3.1 GSK Non-alcoholic Steatohepatitis Basic Information
9.3.2 GSK Non-alcoholic Steatohepatitis Product Overview
9.3.3 GSK Non-alcoholic Steatohepatitis Product Market Performance
9.3.4 GSK Non-alcoholic Steatohepatitis SWOT Analysis
9.3.5 GSK Business Overview
9.3.6 GSK Recent Developments
9.4 Novo Nordisk
9.4.1 Novo Nordisk Non-alcoholic Steatohepatitis Basic Information
9.4.2 Novo Nordisk Non-alcoholic Steatohepatitis Product Overview
9.4.3 Novo Nordisk Non-alcoholic Steatohepatitis Product Market Performance
9.4.4 Novo Nordisk Business Overview
9.4.5 Novo Nordisk Recent Developments
9.5 Roche
9.5.1 Roche Non-alcoholic Steatohepatitis Basic Information
9.5.2 Roche Non-alcoholic Steatohepatitis Product Overview
9.5.3 Roche Non-alcoholic Steatohepatitis Product Market Performance
9.5.4 Roche Business Overview
9.5.5 Roche Recent Developments
9.6 AbbVie
9.6.1 AbbVie Non-alcoholic Steatohepatitis Basic Information
9.6.2 AbbVie Non-alcoholic Steatohepatitis Product Overview
9.6.3 AbbVie Non-alcoholic Steatohepatitis Product Market Performance
9.6.4 AbbVie Business Overview
9.6.5 AbbVie Recent Developments
9.7 Galectin Therapeutics
9.7.1 Galectin Therapeutics Non-alcoholic Steatohepatitis Basic Information
9.7.2 Galectin Therapeutics Non-alcoholic Steatohepatitis Product Overview
9.7.3 Galectin Therapeutics Non-alcoholic Steatohepatitis Product Market Performance
9.7.4 Galectin Therapeutics Business Overview
9.7.5 Galectin Therapeutics Recent Developments
9.8 Galmed Pharmaceuticals
9.8.1 Galmed Pharmaceuticals Non-alcoholic Steatohepatitis Basic Information
9.8.2 Galmed Pharmaceuticals Non-alcoholic Steatohepatitis Product Overview
9.8.3 Galmed Pharmaceuticals Non-alcoholic Steatohepatitis Product Market Performance
9.8.4 Galmed Pharmaceuticals Business Overview
9.8.5 Galmed Pharmaceuticals Recent Developments
9.9 Gilead
9.9.1 Gilead Non-alcoholic Steatohepatitis Basic Information
9.9.2 Gilead Non-alcoholic Steatohepatitis Product Overview
9.9.3 Gilead Non-alcoholic Steatohepatitis Product Market Performance
9.9.4 Gilead Business Overview
9.9.5 Gilead Recent Developments
9.10 Intercept pharma
9.10.1 Intercept pharma Non-alcoholic Steatohepatitis Basic Information
9.10.2 Intercept pharma Non-alcoholic Steatohepatitis Product Overview
9.10.3 Intercept pharma Non-alcoholic Steatohepatitis Product Market Performance
9.10.4 Intercept pharma Business Overview
9.10.5 Intercept pharma Recent Developments
9.11 Non-alcoholic Steatohepatitis
9.11.1 Non-alcoholic Steatohepatitis Non-alcoholic Steatohepatitis Basic Information
9.11.2 Non-alcoholic Steatohepatitis Non-alcoholic Steatohepatitis Product Overview
9.11.3 Non-alcoholic Steatohepatitis Non-alcoholic Steatohepatitis Product Market Performance
9.11.4 Non-alcoholic Steatohepatitis Business Overview
9.11.5 Non-alcoholic Steatohepatitis Recent Developments
9.12 Takeda
9.12.1 Takeda Non-alcoholic Steatohepatitis Basic Information
9.12.2 Takeda Non-alcoholic Steatohepatitis Product Overview
9.12.3 Takeda Non-alcoholic Steatohepatitis Product Market Performance
9.12.4 Takeda Business Overview
9.12.5 Takeda Recent Developments
10 Non-alcoholic Steatohepatitis Market Forecast by Region
10.1 Global Non-alcoholic Steatohepatitis Market Size Forecast
10.2 Global Non-alcoholic Steatohepatitis Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Non-alcoholic Steatohepatitis Market Size Forecast by Country
10.2.3 Asia Pacific Non-alcoholic Steatohepatitis Market Size Forecast by Region
10.2.4 South America Non-alcoholic Steatohepatitis Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Non-alcoholic Steatohepatitis by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Non-alcoholic Steatohepatitis Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Non-alcoholic Steatohepatitis by Type (2025-2030)
11.1.2 Global Non-alcoholic Steatohepatitis Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Non-alcoholic Steatohepatitis by Type (2025-2030)
11.2 Global Non-alcoholic Steatohepatitis Market Forecast by Application (2025-2030)
11.2.1 Global Non-alcoholic Steatohepatitis Sales (K Units) Forecast by Application
11.2.2 Global Non-alcoholic Steatohepatitis Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings